2020
DOI: 10.1016/j.hrthm.2020.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association

Abstract: Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this joint article from representatives of the Heart Rhythm Society, the American College of Cardiology, and the American Heart Association, we identify the potential risks of exposure to patients, allied healthcare staff, industry representatives, and hospital administrators.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
278
1
14

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 266 publications
(298 citation statements)
references
References 16 publications
5
278
1
14
Order By: Relevance
“…Also, medications are currently used empirically to treat COVID-19 may have side effects and drug interactions, e.g., chloroquine and hydroxychloroquine are known to prolong the QT interval which can potentially lead to fatal side effects [72]. Close monitoring of ECG is therefore required for COVID-19 patients with QT prolonging medications [73]. Furthermore, wearable based tele-ECG monitoring instead of standard vital sign checks by medical staff can potentially reduce cross-infections through reducing staff to patient contact.…”
Section: A Electrocardiogram For Monitoring Cvd and Covid-19 Patientsmentioning
confidence: 99%
See 3 more Smart Citations
“…Also, medications are currently used empirically to treat COVID-19 may have side effects and drug interactions, e.g., chloroquine and hydroxychloroquine are known to prolong the QT interval which can potentially lead to fatal side effects [72]. Close monitoring of ECG is therefore required for COVID-19 patients with QT prolonging medications [73]. Furthermore, wearable based tele-ECG monitoring instead of standard vital sign checks by medical staff can potentially reduce cross-infections through reducing staff to patient contact.…”
Section: A Electrocardiogram For Monitoring Cvd and Covid-19 Patientsmentioning
confidence: 99%
“…With a surge of COVID-19 case at the time of writing, the United States has transitioned rapidly to telemedicine by relaxing prior telemedicine rules [162]. There are also specific guidelines recommending telehealth and remote checks whenever feasible to reduce direct contact as well as to limit the time and personnel resource in clinic rooms [73].…”
Section: Mobile Health and Telemedicine Technology For Trackingmentioning
confidence: 99%
See 2 more Smart Citations
“…As per the recent consensus statement from the Heart Rhythm Society, American Heart Association and American College of Cardiology, only urgent and emergent procedures were performed during the current upswing of the COVID‐19 infection curve to minimize virus transmission between patients and providers 7 . Emergent procedures according to clinical discretion may include cardioversion, implantation of temporary or permanent pacemaker (PPM), or ablation for arrhythmias refractory to medical management.…”
Section: Introductionmentioning
confidence: 99%